| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Accidental guanethidine poisoning |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional guanethidine poisoning |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par la guanéthidine d'intention indéterminée |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine adverse reaction |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to guanethidine (finding) |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine overdose |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental guanethidine overdose (disorder) |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional guanethidine overdose |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de guanéthidine d'intention indéterminée |
Causative agent (attribute) |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine monosulfate [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 10mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 3% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate+epinephrine 1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate+adrenaline 0.5%/0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guanethidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely guanethidine monosulfate 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Poisoning caused by guanethidine (disorder) |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine monosulfate (substance) |
Is a |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine monosulfate+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental guanethidine poisoning |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional guanethidine poisoning |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine block |
Direct substance |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing epinephrine and guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing guanethidine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guanethidine block |
Direct substance |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to guanethidine (finding) |
Causative agent (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine monosulfate (substance) |
Is modification of (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guanethidine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine- and hydrochlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing guanethidine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adrenaline- and guanethidine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adrenaline and guanethidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Guanethidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only guanethidine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adrenaline and guanethidine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Guanethidine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only guanethidine and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only guanethidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine 5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine 5 mg/mL eye solution |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine 20 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine 20 mg/mL eye solution |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine 30 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guanethidine 30 mg/mL eye solution |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
Has precise active ingredient |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Guanethidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]